𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating markers of biliary malignancy: opportunities in proteomics?

✍ Scribed by Glenn K Bonney; Rachel A Craven; Raj Prasad; Alan F Melcher; Peter J Selby; Rosamonde E Banks

Book ID
117784620
Publisher
The Lancet
Year
2008
Tongue
English
Weight
547 KB
Volume
9
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Circulating tumor markers in the monitor
Circulating tumor markers in the monitoring of gynecologic malignancies
✍ Peter E. Schwartz; Setsuko K. Chambers; Joseph T. Chambers; Jacqueline Gutmann; πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 751 KB

Plasma from 262 patients with gynecologic malignancies was assayed for levels of circulating tumor markers (CA 125, LSA [lipid associated sialic acid in plasma, LASA-P (Dianon Systems, Inc., Stratford, CT )], Ca 19-9, and carcinoembryonic antigen [CEA]) and correlated with the patients' clinical sta

Serial circulating markers of inflammati
Serial circulating markers of inflammation in biliary atresiaβ€”Evolution of the post-operative inflammatory process
✍ Bommayya Narayanaswamy; Christopher Gonde; J. Michael Tredger; Munther Hussain; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 444 KB

Biliary atresia (BA) may be characterized as an occlusive cholangiopathy affecting both intra- and extra-hepatic parts of the biliary tree, together with a pronounced inflammatory response consisting of hepatic infiltration of (predominantly) CD4+ lymphocytes and macrophages. Soluble cellular adhesi